Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+9.95%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$39.9B
AUM Growth
+$39.9B
(+2.3%)
Cap. Flow
-$403M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
199
Reduced
390
Closed
98
Top Buys
| 1 |
Apple
AAPL
|
$1.55B |
| 2 |
Johnson & Johnson
JNJ
|
$172M |
| 3 |
Sensata Technologies
ST
|
$154M |
| 4 |
Bristol-Myers Squibb
BMY
|
$134M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
$102M |
Top Sells
| 1 |
Otis Worldwide
OTIS
|
$167M |
| 2 |
Ross Stores
ROST
|
$115M |
| 3 |
Five Below
FIVE
|
$100M |
| 4 |
Freeport-McMoran
FCX
|
$100M |
| 5 |
Fortune Brands Innovations
FBIN
|
$95.4M |
Sector Composition
| 1 | Technology | 23.11% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Financials | 11.28% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
IQVIA
IQV
$32.4B
| $33.4M | 0.08% |
212,200
+8,400
| +4% | +$1.32M |
|
252
ChargePoint
CHPT
$263M
| $33.4M | 0.08% |
2,140,948
-259,052
| -11% | -$4.04M |
|
253
MSCI
MSCI
$43.9B
| $33.3M | 0.08% |
93,400
-4,800
| -5% | -$1.71M |
|
|
BMY.RT
254
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $33.3M | 0.08% |
14,800,000
+1,084,159
| +8% | +$2.44M |
|
255
Synopsys
SNPS
$112B
| $33.1M | 0.08% |
154,900
-17,100
| -10% | -$3.66M |
|
256
Marathon Petroleum
MPC
$54.6B
| $33M | 0.08% |
1,125,710
+176,400
| +19% | +$5.18M |
|
|
TXNM
257
TXNM Energy, Inc.
TXNM
$5.97B
| $32.9M | 0.08% |
796,344
-250,000
| -24% | -$10.3M |
|
258
Corteva
CTVA
$50.4B
| $32.7M | 0.08% |
1,135,237
+296,380
| +35% | +$8.54M |
|
259
PACCAR
PCAR
$52.5B
| $32.6M | 0.08% |
382,442
+84,247
| +28% | +$7.18M |
|
260
KLA
KLAC
$115B
| $32.3M | 0.08% |
166,570
-37,800
| -18% | -$7.32M |
|
|
FLIR
261
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $32.1M | 0.08% |
896,312
+698,214
| +352% | +$25M |
|
262
MetLife
MET
$54.1B
| $32.1M | 0.08% |
863,326
+17,000
| +2% | +$632K |
|
263
Jazz Pharmaceuticals
JAZZ
$7.75B
| $32.1M | 0.08% |
225,000
| – | – |
|
264
F5
FFIV
$18B
| $32M | 0.08% |
260,600
+67,200
| +35% | +$8.25M |
|
265
Applied Materials
AMAT
$128B
| $31.7M | 0.08% |
533,926
-10,376
| -2% | -$617K |
|
|
ANSS
266
DELISTED
Ansys
ANSS
| $31.5M | 0.08% |
96,400
-3,100
| -3% | -$1.01M |
|
267
Voya Financial
VOYA
$7.24B
| $31.2M | 0.08% |
650,200
+400,000
| +160% | +$19.2M |
|
268
Semtech
SMTC
$5.04B
| $31.1M | 0.08% |
588,127
+156,000
| +36% | +$8.26M |
|
269
Adient
ADNT
$2.01B
| $31M | 0.08% |
1,787,531
+336,479
| +23% | +$5.83M |
|
|
WPX
270
DELISTED
WPX Energy, Inc.
WPX
| $31M | 0.08% |
6,321,800
-1,400,000
| -18% | -$6.86M |
|
271
Public Service Enterprise Group
PEG
$41.1B
| $30.9M | 0.08% |
562,984
-1,203,200
| -68% | -$66.1M |
|
272
Yum! Brands
YUM
$40.8B
| $30.6M | 0.08% |
334,891
-10,900
| -3% | -$995K |
|
|
XEC
273
DELISTED
CIMAREX ENERGY CO
XEC
| $30.4M | 0.08% |
1,250,309
+369,654
| +42% | +$8.99M |
|
274
Celldex Therapeutics
CLDX
$1.47B
| $30.4M | 0.08% |
2,050,000
+300,000
| +17% | +$4.45M |
|
275
Visteon
VC
$3.38B
| $30.1M | 0.08% |
435,497
-56,665
| -12% | -$3.92M |
|